Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People with type 1 diabetes who have been using a Dexcom or Abbott Libre glucose sensor (any model) for at least 14 days before the pump is set up, with the sensor recording data at least 70% of the time during that period
- People for whom a diabetes specialist has decided to start them on the mylife CamAPS FX hybrid closed-loop system
- People who have received information about the study and agreed to take part and to have their personal data used
- Adults who have signed a consent form, or children whose parents have signed a consent form on their behalf
- Adults, or children old enough to fill in questionnaires, or parents of a child participant, who are able to read and understand French
- Adults, or children old enough to fill in questionnaires, or parents of a child participant, who agree to complete online questionnaires
Who may not be able to join:
- People who have used any hybrid closed-loop, fully closed-loop, or do-it-yourself loop insulin system (any brand or model) in the past 6 months
- People currently taking part in, or who took part in, another clinical trial in the previous month that does not allow participation in other studies
- People, or parents of a child participant, who are not able to give consent
- People who are under a legal protection measure, such as guardianship, curatorship, or legal safeguard
- People for whom the mylife CamAPS FX system is not medically appropriate according to the device's official instructions for use (confirm with trial site)
- People who have an unresolved skin condition in the area where the sensor or tubing would be placed — for example, psoriasis, a rash, dermatitis herpetiformis, or a skin infection
- People with unstable diabetic eye disease (retinopathy) that requires laser treatment
- People with another condition or treatment that affects blood sugar levels in a way the investigator considers likely to significantly impact blood sugar management (confirm with trial site)
- People whose follow-up care cannot be carried out by the trial centre — for example, if a move is planned within 12 months of joining
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ingo Braun, mylife Diabetes Care
Phone: +41582347132
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Time in Range (TIR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.